Is the performance on pretreatment exposure, assessed by the BAT-procedure, related to symptom change after 12 weeks of specialized clinical CBT, in patients with Obsessive-Compulsive Disorder?

Is the performance on pretreatment exposure, assessed by the BAT-procedure, related to symptom change after 12 weeks of specialized clinical CBT, in patients with Obsessive-Compulsive Disorder? - Is pretreament exposure related to symptom change in patients with OCD?

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON43347

Enrollment

Registered

2017-01-03

Start date

2017-01-01

Completion date

Unknown

Last updated

2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

obsessive compulsive disorder

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Referred patients (aged >18years), who meet a primary DSM-IV diagnosis of OCD, follow a specialized residential treatment with CBT as main component and give informed consent.

Exclusion criteria

Exclusion criteria: Referred patients suffering from a psychotic disorder, an organic mental disorder, substance dependence, or mental retardation.

Design outcomes

Primary

Measure	Time frame
Dependent variables: 1/ Difference in score on YBOCS assessed at start of treatment and after 12 weeks (continuous data); 2/ Response to treatment (>=35% OCD symptom reduction) yes/no; 3/ Remission (post-treatment YBOCS score	—

Secondary

Measure	Time frame
Secondary outcome measures will be - Difference in score on quality of life, assessed by the Euroquol at start of treatment and after 12 weeks. - Proportion of dropouts. - Outcome at 16 and 40 weeks.	—

Countries

Netherlands

Outcome results